QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.58 (+1.16%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-2.34%)
GE   101.53 (-0.86%)
DIS   87.96 (+0.16%)
AMC   4.51 (-2.59%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)
QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.58 (+1.16%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-2.34%)
GE   101.53 (-0.86%)
DIS   87.96 (+0.16%)
AMC   4.51 (-2.59%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)
QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.58 (+1.16%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-2.34%)
GE   101.53 (-0.86%)
DIS   87.96 (+0.16%)
AMC   4.51 (-2.59%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)
QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.58 (+1.16%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-2.34%)
GE   101.53 (-0.86%)
DIS   87.96 (+0.16%)
AMC   4.51 (-2.59%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)
NASDAQ:MTP

Biodexa Pharmaceuticals (MTP) Institutional Ownership

Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
N/A
50-Day Range
$0.29
▼
$3.22
52-Week Range
N/A
Volume
164,300 shs
Average Volume
57,354 shs
Market Capitalization
$6.18 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

Institutional Ownership Changes (13F Filings) for Biodexa Pharmaceuticals (NASDAQ:MTP)

Current
Institutional Ownership
Percentage
4.21%
Number of
Institutional Buyers
(last 12 months)
2
Total
Institutional Inflows
(last 12 months)
$2.06 M
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$1.22 M
Skip Chart & View Institutional Buying and Selling Data

MTP Institutional Buying and Selling by Quarter

Get MTP Insider Trade Alerts

Want to know when executives and insiders are buying or selling Biodexa Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


Biodexa Pharmaceuticals Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/15/2023Armistice Capital LLC386,828$0.38M0.0%N/A1.785%
11/14/2022Renaissance Technologies LLC37,567$70K0.0%-81.4%0.953%
7/19/2022Great Valley Advisor Group Inc.49,600$27K0.0%N/A0.252%
11/15/2021Lombard Odier Asset Management USA Corp295,500$0.38M0.0%-50.0%2.331%
11/12/2021Renaissance Technologies LLC219,137$0.38M0.0%+4.1%1.729%
9/17/2021Virtu Financial LLC16,735$35K0.0%-65.7%0.132%
8/16/2021Credit Suisse AG38,716$81K0.0%N/A0.305%
8/13/2021Renaissance Technologies LLC210,485$0.44M0.0%-40.0%1.661%
8/13/2021Lombard Odier Asset Management USA Corp591,000$1.06M0.0%+49.4%4.662%
8/6/2021StoneX Group Inc.32,484$68K0.0%N/A0.256%
5/18/2021Lombard Odier Asset Management USA Corp395,500$0.61M0.0%N/A3.120%
5/18/2021Citadel Advisors LLC141,109$0.30M0.0%+727.0%1.113%
5/13/2021Renaissance Technologies LLC351,037$0.75M0.0%+95.6%2.769%
5/12/2021UBS Group AG24,372$52K0.0%+2,371.8%0.192%
3/26/2021Susquehanna International Group LLP84,695$0.16M0.0%+144.0%0.668%
2/24/2021Virtu Financial LLC51,602$97K0.0%N/A0.409%
2/10/2021Renaissance Technologies LLC179,500$0.34M0.0%+18.2%1.423%
11/13/2020Morgan Stanley58,630$0.11M0.0%N/A0.465%
10/20/2020Wedbush Securities Inc.14,039$25K0.0%N/A0.111%
7/31/2020UBS Group AG30,864$42K0.0%+939.5%0.473%
2/13/2020Renaissance Technologies LLC148,797$0.10M0.0%N/A4.864%
2/4/2020Virtu Financial LLC59,378$41K0.0%N/A1.940%
8/14/2019Morgan Stanley50,000$72K0.0%N/A1.635%
(Data available from 1/1/2016 forward)













MTP Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of MTP shares?

During the previous two years, the following institutional investors and hedge funds held shares of Biodexa Pharmaceuticals shares: Lombard Odier Asset Management USA Corp ($0.38M), Armistice Capital LLC ($0.38M), Credit Suisse AG ($81K), Renaissance Technologies LLC ($70K), StoneX Group Inc. ($68K), and Virtu Financial LLC ($35K), and Great Valley Advisor Group Inc. ($27K).Learn more on MTP's institutional investors.

What percentage of Biodexa Pharmaceuticals stock is owned by institutional investors?

4.21% of Biodexa Pharmaceuticals stock is owned by institutional investors. Learn more on MTP's institutional investor holdings.

Which institutional investors have been buying Biodexa Pharmaceuticals stock?

The following institutional investors have purchased Biodexa Pharmaceuticals stock in the last 24 months: Armistice Capital LLC ($0.39M), Lombard Odier Asset Management USA Corp ($0.20M), Great Valley Advisor Group Inc. ($49.60K), Credit Suisse AG ($38.72K), StoneX Group Inc. ($32.48K), and Renaissance Technologies LLC ($8.65K).

How much institutional buying is happening at Biodexa Pharmaceuticals?

Institutional investors have bought a total of 711,780 shares in the last 24 months. This purchase volume represents approximately $13.46M in transactions.

Which Biodexa Pharmaceuticals major shareholders have been selling company stock?

The following institutional investors have sold Biodexa Pharmaceuticals stock in the last 24 months: Renaissance Technologies LLC ($0.30M), Lombard Odier Asset Management USA Corp ($0.30M), and Virtu Financial LLC ($31.99K).

How much institutional selling is happening at Biodexa Pharmaceuticals?

Institutional investors have sold a total of 632,011 shares in the last 24 months. This volume of shares sold represents approximately $18.68M in transactions.


Related Companies:
This page (NASDAQ:MTP) was last updated on 5/31/2023 by MarketBeat.com Staff

My Account -